Table 1:
Model type | Major advantages for research | Factors impacting genomic evolution | |
---|---|---|---|
Genetically-engineered mouse models |
* De novo tumorigenesis in vivo * Interactions with the microenvironment and with other cell types |
* Somatic evolution of the tumor as an integral part of tumorigenesis * Germline evolution of the host throughout colony propagation |
|
Patient-derived models | New cancer cell lines | * Short time and few cell divisions from primary tumors to functional assays | * Physical constraints (2D) * Variations in culture conditions (media, passaging practices, etc.) * Continuous selection for rapidly proliferating cells |
Established cancer cell lines | * Widely accessible and easy to work with * Ample genomic data available |
* Numerous cell divisions * Variations in culture conditions * Deficient mechanisms of genome maintenance inherited from tumor of origin |
|
Xenografts | * No growth on plastic * Functional investigation of human tumors in vivo |
* Differences in physiology and metabolism between species * Immune-deficient environment * Site of transplantation * Multiple cell divisions within each passage |
|
Organoids | * Complex cellular interactions * Culture conditions mimic in vivo conditions better than 2D culture * 3D environment * Matched normal controls |
* Variations in culture conditions * Deficient mechanisms of genome maintenance inherited from tumor of origin * Immune-deficient environment |